ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,232.00
0.00%
S&P 500
5,321.41
0.25%
US Dollar vs CAD
1.36471
0.05%
Bitcoin
69,775.91
-0.51%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Arcus Biosciences Inc (RCUS)

  7. Arcus Biosciences Inc (RCUS) News

RCUS

Arcus Biosciences (RCUS)

Arcus Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:RCUS
DateTimeSourceHeadlineSymbolCompany
05/09/20243:35PMBusiness WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
05/08/20243:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:RCUSArcus Biosciences Inc
05/08/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:RCUSArcus Biosciences Inc
05/08/20243:02PMBusiness WireArcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline UpdateNYSE:RCUSArcus Biosciences Inc
05/02/20243:05PMBusiness WireArcus Biosciences to Participate in the Bank of America Healthcare Conference 2024NYSE:RCUSArcus Biosciences Inc
04/24/20243:00PMBusiness WireArcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual MeetingNYSE:RCUSArcus Biosciences Inc
04/23/20243:05PMBusiness WireArcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline UpdateNYSE:RCUSArcus Biosciences Inc
04/09/20243:35PMBusiness WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
03/26/20243:35PMBusiness WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
03/11/20243:35PMBusiness WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
02/28/20243:05PMBusiness WireArcus Biosciences to Participate in Two Upcoming Investor ConferencesNYSE:RCUSArcus Biosciences Inc
02/27/20243:35PMBusiness WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
02/21/20243:53PMEdgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:RCUSArcus Biosciences Inc
02/21/20243:32PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:RCUSArcus Biosciences Inc
02/21/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:RCUSArcus Biosciences Inc
02/21/20243:05PMBusiness WireArcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline UpdateNYSE:RCUSArcus Biosciences Inc
02/09/20243:35PMBusiness WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
02/07/20245:58PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
02/07/20244:00PMBusiness WireArcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline UpdatesNYSE:RCUSArcus Biosciences Inc
01/30/20247:17AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:RCUSArcus Biosciences Inc
01/30/20245:25AMIH Market NewsArcus Biosciences Stock Jumps 20% on $320M Gilead Investment, Super Micro Surpasses Forecasts, and More NewsNYSE:RCUSArcus Biosciences Inc
01/29/20244:00PMBusiness WireGilead and Arcus Announce Amended Collaboration and Equity InvestmentNYSE:RCUSArcus Biosciences Inc
01/29/20244:00PMBusiness WireGilead and Arcus Announce Amended Collaboration and Equity InvestmentNYSE:RCUSArcus Biosciences Inc
01/26/20243:35PMBusiness WireArcus Biosciences Announces New Employment Inducement GrantsNYSE:RCUSArcus Biosciences Inc
01/25/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
01/25/20246:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
01/25/20246:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
01/16/20244:00PMBusiness WireData from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic CancerNYSE:RCUSArcus Biosciences Inc
12/22/20233:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
12/20/20233:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:RCUSArcus Biosciences Inc
 Showing the most relevant articles for your search:NYSE:RCUS

Your Recent History

USOTC
QEDN
QED Connect (PK)
USOTC
SRMX
Saddle Ranch Media (PK)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
WNFT
Worldwide NFT (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
WDLF
Decentral Life (PK)
USOTC
ERHE
ERHC Energy (CE)
NASDAQ
LWLG
Lightwave Logic
USOTC
DPLS
DarkPulse (PK)
USOTC
CNNA
Cann American (CE)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
GDVM
Global Developments (PK)
USOTC
PSRU
Valiant Eagle (PK)
NASDAQ
TLRY
Tilray Brands
USOTC
SONGD
Music Licensing (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved